A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus

NCT03218501 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

269

Enrollment

INDUSTRY

Sponsor class

Conditions

Uremic Pruritus in Hemodialysis Patients

Interventions

DRUG: SK-1405 high dose
DRUG: SK-1405 low dose
DRUG: Placebo

Sponsor

Sanwa Kagaku Kenkyusho Co., Ltd.